These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 33964437)
21. Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents. Verma G; Chashoo G; Ali A; Khan MF; Akhtar W; Ali I; Akhtar M; Alam MM; Shaquiquzzaman M Bioorg Chem; 2018 Apr; 77():106-124. PubMed ID: 29353728 [TBL] [Abstract][Full Text] [Related]
23. Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation. Li YB; Yan X; Li RD; Liu P; Sun SQ; Wang X; Cui JR; Zhou DM; Ge ZM; Li RT Eur J Med Chem; 2016 Apr; 112():217-230. PubMed ID: 26900655 [TBL] [Abstract][Full Text] [Related]
24. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line. Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity. Hassan RA; Emam SH; Hwang D; Kim GD; Hassanin SO; Khalil MG; Abdou AM; Sonousi A Bioorg Chem; 2022 Jan; 118():105487. PubMed ID: 34798455 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and Hela cancer cells. Zhao B; Zhao C; Hu X; Xu S; Lan Z; Guo Y; Yang Z; Zhu W; Zheng P Eur J Med Chem; 2020 Jan; 185():111809. PubMed ID: 31683104 [TBL] [Abstract][Full Text] [Related]
27. Development of 1,3,4-oxadiazole thione based novel anticancer agents: Design, synthesis and in-vitro studies. Yadav N; Kumar P; Chhikara A; Chopra M Biomed Pharmacother; 2017 Nov; 95():721-730. PubMed ID: 28888209 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors. Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents. Lakshmithendral K; Saravanan K; Elancheran R; Archana K; Manikandan N; Arjun HA; Ramanathan M; Lokanath NK; Kabilan S Eur J Med Chem; 2019 Apr; 168():1-10. PubMed ID: 30798049 [TBL] [Abstract][Full Text] [Related]
31. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition. Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells. Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490 [TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity. Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of novel imidazo[1,2-a]pyridine-oxadiazole hybrids as anti-proliferative agents: Study of microtubule polymerization inhibition and DNA binding. Sigalapalli DK; Kiranmai G; Parimala Devi G; Tokala R; Sana S; Tripura C; Jadhav GS; Kadagathur M; Shankaraiah N; Nagesh N; Babu BN; Tangellamudi ND Bioorg Med Chem; 2021 Aug; 43():116277. PubMed ID: 34175586 [TBL] [Abstract][Full Text] [Related]
35. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study. AboulWafa OM; Daabees HMG; Badawi WA Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors. Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives. Li H; Wang K; Wan Q; Chen Y Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816 [TBL] [Abstract][Full Text] [Related]
38. Discovery of novel furo[2,3-d]pyrimidin-2-one-1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis. El Mansouri AE; Oubella A; Dânoun K; Ahmad M; Neyts J; Jochmans D; Snoeck R; Andrei G; Morjani H; Zahouily M; Lazrek HB Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100146. PubMed ID: 34128255 [TBL] [Abstract][Full Text] [Related]